Paul J. Galardy
- Molecular Biology top 5%
- Oncology top 5%
- Cell Biology top 5%
- Cancer Research top 10%
- Immunology top 10%
- Co-authors
- Hidde L. PloeghSajjad HussainHuib OvaaBenedikt M. KesslerYing ZhangEdda FiebigerJan van DeursenRené Bernards
- Topics
- Ubiquitin and proteasome pathways (28 papers)Protein Degradation and Inhibitors (11 papers)Lymphoma Diagnosis and Treatment (11 papers)
- Journals
- Proceedings of the National Academy of SciencesJournal of Biological ChemistryAngewandte Chemie International Edition
- Partner nations
- United StatesNetherlandsItaly
In The Last Decade
Paul J. Galardy
52 papers receiving 2.7k citations
Peers
Comparison fields: 5 of 91
- Molecular Biology 2.3k
- Oncology 971
- Cell Biology 391
- Cancer Research 298
- Immunology 256
Countries citing papers authored by Paul J. Galardy
This map shows the geographic impact of Paul J. Galardy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul J. Galardy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul J. Galardy more than expected).
Fields of papers citing papers by Paul J. Galardy
This network shows the impact of papers produced by Paul J. Galardy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul J. Galardy. The network helps show where Paul J. Galardy may publish in the future.
Co-authorship network of co-authors of Paul J. Galardy
This figure shows the co-authorship network connecting the top 25 collaborators of Paul J. Galardy. A scholar is included among the top collaborators of Paul J. Galardy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul J. Galardy. Paul J. Galardy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 0 | |
| 5 | 2 | |
| 6 | 9 | |
| 7 | 16 | |
| 8 | 32 | |
| 9 | 14 | |
| 10 | 9 | |
| 11 | 55 | |
| 12 | 105 | |
| 13 | 209 | |
| 14 | 76 | |
| 15 | 85 | |
| 16 | 466 | |
| 17 | 14 | |
| 18 | 13 | |
| 19 | 220 | |
| 20 | 147 |
About Paul J. Galardy
Paul J. Galardy is a scholar working on Hematology, Genetics and Oncology, having authored 55 papers that have together received 2.8k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (28 papers), Protein Degradation and Inhibitors (11 papers) and Lymphoma Diagnosis and Treatment (11 papers). The work is most often cited by research in Oncology (971 citations), Molecular Biology (2.3k citations) and Cell Biology (391 citations). Paul J. Galardy has collaborated with scholars based in United States, Netherlands and Italy. Frequent co-authors include Hidde L. Ploegh, Sajjad Hussain, Huib Ovaa, Benedikt M. Kessler, Ying Zhang, Edda Fiebiger, Jan van Deursen, René Bernards, Alan D. D’Andrea and Sebastian Nijman. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Angewandte Chemie International Edition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.